A case of simvastatin-associated pancreatitis and review of statin-associated pancreatitis

Pharmacotherapy

Volumn 26, Issue 3, 2006, Pages 414-422

  Johnson, Jeremy L ^a   Loomis, Ilana B ^b  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Drug induced pancreatitis; Pancreatitis; Simvastatin; Statin

Indexed keywords

ACETYLSALICYLIC ACID; ALUMINUM MAGNESIUM HYDROXIDE; AMLODIPINE; CEFTRIAXONE; CERIVASTATIN; GLIBENCLAMIDE; INSULIN; LIDOCAINE; LISINOPRIL; LOW DENSITY LIPOPROTEIN; METFORMIN; PETHIDINE; PHENOBARBITAL; ROSIGLITAZONE; SCOPOLAMINE; SIMETHICONE; SIMVASTATIN; STATINE DERIVATIVE; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; ADULT; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; DRUG MIXTURE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FOLLOW UP; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MUSCLE WEAKNESS; MYALGIA; NAUSEA; PAIN; SIDE EFFECT;

HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PANCREATITIS; SIMVASTATIN;

EID: 33644690903     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.3.414     Document Type: Article

References (37)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-97.
2. Merck and Co., Inc. Zocor (simvastatin) package insert. Whitehouse Station, NJ; 2003.
3. Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C. ACC/AHA/NHLBI advisory on the use and safety of statins. Circulation 2002;106:1024-8.
4. Vaczek D. Top 200 prescription drugs of 2003. Pharm Times 2004;70:46-54.
5. Vaczek D. Top 200 drugs of 2002. Pharm Times 2003;69:20-6.
6. Latner AW. The top 200 of 2000: drugs of the new millennium. Pharm Times 2001;67:14-38.
7. Latner AW. The top 200 drugs of 1999. Pharm Times 2000;66:16-32.
8. Buckley B. 34th Annual top 200 drugs issue. Pharm Times 1999;65:16-22.
9. Anonymous. Top 200 drugs of 1997. Pharm Times 1998;64: 31-49.
10. Grundy SM, Cleeman JI, Merz CN, et al, National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, American Heart Association. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004;110:227-39.
11. Berardi RR, Montgomery PA. Pancreatitis. In: DiPiro JT, Talbert RL, Yee GC, et al, eds. Pharmacotherapy: a pathophysiologic approach, 5th ed. New York: McGraw-Hill, 2002:701-15.
12. Swaroop VS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA 2004;291:2865-8.
13. Eland IA, van Puijenbroek EP, Sturkenboom MJ, Wilson JH, Stricker BH. Drug-associated acute pancreatitis: 21 years of spontaneous reporting in the Netherlands. Am J Gastroenterol 1999;94:2417-22.
14. Wilmink T, Frick TW. Drug-induced pancreatitis. Drug Safety 1996;14:406-23.
15. Lankisch PG, Droge M, Gottesleben F. Drug induced acute pancreatitis: incidence and severity. Gut 1995;37:565-7.
16. Bergholm U, Langman M, Rawlins M, et al. Drug-induced acute pancreatitis. Pharmacoepidemiol Drug Safety 1995;4:329-34.
17. Pluhar W. A case of possible lovastatin-induced pancreatitis in concomitant Gilbert syndrome. Wien Klin Wochenschr 1989;101:551-4.
18. Miller LG, Tan G. Drug-induced pancreatitis (lisinopril). J Am Board Fam Pract 1999;12:150-3.
19. Abdul-Ghaffar NU, el-Sonbaty MR. Pancreatitis and rhabdomyolysis associated with lovastatin-gemfibrozil therapy. J Clin Gastroenterol 1995;21:340-1.
20. Belaiche G, Ley G, Slama JL. Acute pancreatitis associated with atorvastatin therapy. Gastroenterol Clin Biol 2000;24:471-2.
21. Miltiadous G, Anthopoulou A, Elisaf M. Acute pancreatitis possibly associated with combined salicylate and atorvastatin therapy. J Pancreas (online) 2003;4:20-1. Available from www.joplink.net.
22. Kanbay M, Sekuk H, Yilmaz U, Gur G, Boyacioglu S. Acute pancreatitis associated with combined lisinopril and atorvastatin therapy. Dig Dis 2005;23:92-4.
23. Singh S, Nautiyal A, Dolan JG. Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect? J Pancreas (online) 2004;5:502-4. Available from www.joplink.net.
24. Anagnostopoulos GK, Stavros T, Margantinis G, Kostopoulos P, Arvanitidis D. Acute pancreatitis due to pravastatin therapy. J Pancreas (online) 2003;4:129-32. Available from www.joplink.net.
25. Tysk C, Al-Eryani AY, Shawabkeh AA. Acute pancreatitis induced by fluvastatin therapy. J Clin Gastroenterol 2002;35:406-8.
26. Couderc M, Blanc P, Rouillon JM, Bauret P, Larrey C, Michel H. A new case of simvastatin-induced acute pancreatitis. Gastroenterol Clin Biol 1991;15:986-7.
27. Ramdani M, Schmitt AM, Liautard J, et al. Simvastatin-induced acute pancreatitis: two cases. Gastroenterol Clin Biol 1991;15:986.
28. Andersen V, Sonne J, Andersen M. Spontaneous reports on drug-induced pancreatitis in Denmark from 1968 to 1999. Eur J Clin Pharmacol 2001;57:517-21.
29. Berland Y, Vacher Coponat H, Durand C, Baz M, Laugier R, Musso JL. Rhabdomyolysis with simvastatin use. Nephron 1991;57:365-6.
30. Pezzilli R, Ceciliato R, Corinaldesi R. Acute pancreatitis due to simvastatin therapy: increased severity after rechallenge. Dig Liver Dis 2004;36:639-40.
31. Antonopoulos S, Sotiris M, Kokkoris S, et al. A case of acute pancreatitis possibly associated with combined salicylate and simvastatin treatment. J Pancreas (online) 2005;6:264-8. Available from www.joplink.net.
32. Lons T, Chousterman M. Simvastatin: a new drug responsible for acute pancreatitis? Gastroenterol Clin Biol 1991;15:93-4.
33. Vanhaecke J, Van Cleemput J, Van Lierde J, Daenen W, De Geest H. Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine. Transplantation 1994;58:42-5.
34. McDonald KB, Garber BG, Perreault MM. Pancreatitis associated with simvastatin plus fenofibrate. Ann Pharmacother 2002;36:275-9.
35. Ranson JHC. Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol 1982;77:633-8.
36. Dubois RW, Chawla AJ, Neslusan CA, Smith MW, Wade S. Explaining drug spending trends: does perception match reality? Health Aff 2000;19:231-9.
37. Dubois RW, Alexander CM, Wade S, et al. Growth in use of lipid-lowering therapies: are we targeting the right patients? Am J Manag Care 2002;8:862-7.